Published Erratum
doi: 10.1038/s41591-022-01948-3.
Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
Thomas U Marron
1
2
3
4
5
6
7
8
9
, Matthew D Galsky
10
11
12
13
14
, Bachir Taouli
10
12
15
16
17
18
, Maria Isabel Fiel
10
12
15
16
19
, Stephen Ward
10
12
15
16
19
, Edward Kim
10
12
15
16
18
20
, David Yankelevitz
10
12
21
18
20
, Deborah Doroshow
10
11
12
13
21
, Emma Guttman-Yassky
22
23
24
, Benjamin Ungar
22
23
24
, Saurabh Mehandru
22
23
25
, Benjamin J Golas
10
12
26
, Daniel Labow
10
12
26
, John Sfakianos
10
12
14
, Sujit S Nair
10
12
14
, Dimple Chakravarty
10
12
14
, Michael Buckstein
10
12
15
16
27
, Xiaoyu Song
10
12
28
, Effi Kenigsberg
10
23
29
30
, Sacha Gnjatic
10
12
23
13
21
29
, Brian D Brown
10
12
23
29
30
, Joseph Sparano
10
12
13
29
, Ashutosh Tewari
10
12
14
, Myron Schwartz
10
12
23
15
16
26
, Nina Bhardwaj
10
22
11
12
23
13
21
14
29
, Miriam Merad
31
32
33
34
35
36
37
38
39
40
Affiliations
Affiliations
- 1 The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 2 Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 3 Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 4 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 5 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 6 Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 7 Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 8 Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 9 Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 10 The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 11 Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 12 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 13 Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 14 Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 15 Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 16 Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 17 Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 18 BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 19 Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 20 Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 21 Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 22 Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 23 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 24 Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 25 Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 26 Division of Surgical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 27 Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 28 Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 29 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 30 Department of Genomics and Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 31 The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 32 Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 33 Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 34 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 35 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 36 Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 37 Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 38 Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 39 Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 40 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- PMID: 35851878
- DOI: 10.1038/s41591-022-01948-3
Item in Clipboard
Published Erratum
Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
Thomas U Marron et al.
Nat Med.
2022 Aug.
Display options
Format
doi: 10.1038/s41591-022-01948-3.
Authors
Thomas U Marron
1
2
3
4
5
6
7
8
9
, Matthew D Galsky
10
11
12
13
14
, Bachir Taouli
10
12
15
16
17
18
, Maria Isabel Fiel
10
12
15
16
19
, Stephen Ward
10
12
15
16
19
, Edward Kim
10
12
15
16
18
20
, David Yankelevitz
10
12
21
18
20
, Deborah Doroshow
10
11
12
13
21
, Emma Guttman-Yassky
22
23
24
, Benjamin Ungar
22
23
24
, Saurabh Mehandru
22
23
25
, Benjamin J Golas
10
12
26
, Daniel Labow
10
12
26
, John Sfakianos
10
12
14
, Sujit S Nair
10
12
14
, Dimple Chakravarty
10
12
14
, Michael Buckstein
10
12
15
16
27
, Xiaoyu Song
10
12
28
, Effi Kenigsberg
10
23
29
30
, Sacha Gnjatic
10
12
23
13
21
29
, Brian D Brown
10
12
23
29
30
, Joseph Sparano
10
12
13
29
, Ashutosh Tewari
10
12
14
, Myron Schwartz
10
12
23
15
16
26
, Nina Bhardwaj
10
22
11
12
23
13
21
14
29
, Miriam Merad
31
32
33
34
35
36
37
38
39
40
Affiliations
- 1 The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 2 Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 3 Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 4 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 5 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 6 Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 7 Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 8 Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 9 Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
- 10 The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 11 Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 12 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 13 Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 14 Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 15 Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 16 Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 17 Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 18 BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 19 Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 20 Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 21 Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 22 Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 23 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 24 Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 25 Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 26 Division of Surgical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 27 Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 28 Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 29 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 30 Department of Genomics and Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- 31 The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 32 Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 33 Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 34 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 35 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 36 Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 37 Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 38 Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 39 Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- 40 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Miriam.merad@mssm.edu.
- PMID: 35851878
- DOI: 10.1038/s41591-022-01948-3
Item in Clipboard
Display options
Format
No abstract available
Erratum for
-
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.Marron TU, Galsky MD, Taouli B, Fiel MI, Ward S, Kim E, Yankelevitz D, Doroshow D, Guttman-Yassky E, Ungar B, Mehandru S, Golas BJ, Labow D, Sfakianos J, Nair SS, Chakravarty D, Buckstein M, Song X, Kenigsberg E, Gnjatic S, Brown BD, Sparano J, Tewari A, Schwartz M, Bhardwaj N, Merad M. Marron TU, et al. Nat Med. 2022 Apr;28(4):626-629. doi: 10.1038/s41591-022-01681-x. Nat Med. 2022. PMID: 35347282 Free PMC article.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
